These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 18242387

  • 21. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
    Goessl C, Krause H, Müller M, Heicappell R, Schrader M, Sachsinger J, Miller K.
    Cancer Res; 2000 Nov 01; 60(21):5941-5. PubMed ID: 11085508
    [Abstract] [Full Text] [Related]

  • 22. Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?
    Bernardini S, Miano R, Iori R, Finazzi-Agrò E, Palmieri G, Ballerini S, Angeloni C, Orlandi A, Bellincampi L, Cortese C, Federici G.
    Clin Chim Acta; 2004 Dec 01; 350(1-2):181-8. PubMed ID: 15530476
    [Abstract] [Full Text] [Related]

  • 23. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.
    Prostaglandins Other Lipid Mediat; 2007 Jan 01; 82(1-4):185-97. PubMed ID: 17164146
    [Abstract] [Full Text] [Related]

  • 24. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
    Reibenwein J, Pils D, Horak P, Tomicek B, Goldner G, Worel N, Elandt K, Krainer M.
    Prostate; 2007 Mar 01; 67(4):427-32. PubMed ID: 17192910
    [Abstract] [Full Text] [Related]

  • 25. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
    Ellinger J, Albers P, Perabo FG, Müller SC, von Ruecker A, Bastian PJ.
    J Urol; 2009 Jul 01; 182(1):324-9. PubMed ID: 19447423
    [Abstract] [Full Text] [Related]

  • 26. Correlation between the expression of DNMT1, and GSTP1 and APC, and the methylation status of GSTP1 and APC in association with their clinical significance in prostate cancer.
    Zhang W, Jiao H, Zhang X, Zhao R, Wang F, He W, Zong H, Fan Q, Wang L.
    Mol Med Rep; 2015 Jul 01; 12(1):141-6. PubMed ID: 25738352
    [Abstract] [Full Text] [Related]

  • 27. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
    Jerónimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C, Sidransky D.
    Cancer Epidemiol Biomarkers Prev; 2002 May 01; 11(5):445-50. PubMed ID: 12010858
    [Abstract] [Full Text] [Related]

  • 28. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C, Song JZ, Davidson B, Clark SJ.
    Cancer Res; 2004 Jun 01; 64(11):3871-7. PubMed ID: 15172996
    [Abstract] [Full Text] [Related]

  • 29. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
    Enokida H, Shiina H, Igawa M, Ogishima T, Kawakami T, Bassett WW, Anast JW, Li LC, Urakami S, Terashima M, Verma M, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.
    Cancer Res; 2004 Sep 01; 64(17):5956-62. PubMed ID: 15342374
    [Abstract] [Full Text] [Related]

  • 30. Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
    Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, Walsh PC, Bova GS, De Marzo AM, Isaacs WB, Nelson WG.
    Cancer Res; 2004 Mar 15; 64(6):1975-86. PubMed ID: 15026333
    [Abstract] [Full Text] [Related]

  • 31. Molecular biomarker in prostate cancer: the role of CpG island hypermethylation.
    Bastian PJ, Yegnasubramanian S, Palapattu GS, Rogers CG, Lin X, De Marzo AM, Nelson WG.
    Eur Urol; 2004 Dec 15; 46(6):698-708. PubMed ID: 15548435
    [Abstract] [Full Text] [Related]

  • 32. Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators.
    Ellinger J, Bastian PJ, Haan KI, Heukamp LC, Buettner R, Fimmers R, Mueller SC, von Ruecker A.
    Int J Cancer; 2008 Jan 01; 122(1):138-43. PubMed ID: 17764114
    [Abstract] [Full Text] [Related]

  • 33. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R, Ferdinand L, Reis IM, Schlesselman JJ.
    Oncol Rep; 2004 Sep 01; 12(3):631-7. PubMed ID: 15289848
    [Abstract] [Full Text] [Related]

  • 34. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.
    Woodson K, O'Reilly KJ, Hanson JC, Nelson D, Walk EL, Tangrea JA.
    J Urol; 2008 Feb 01; 179(2):508-11; discussion 511-2. PubMed ID: 18076912
    [Abstract] [Full Text] [Related]

  • 35. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.
    Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ.
    Oncogene; 1999 Feb 11; 18(6):1313-24. PubMed ID: 10022813
    [Abstract] [Full Text] [Related]

  • 36. Gene promoter methylation in prostate tumor-associated stromal cells.
    Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG.
    J Natl Cancer Inst; 2006 Feb 15; 98(4):255-61. PubMed ID: 16478744
    [Abstract] [Full Text] [Related]

  • 37. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.
    Harden SV, Guo Z, Epstein JI, Sidransky D.
    J Urol; 2003 Mar 15; 169(3):1138-42. PubMed ID: 12576869
    [Abstract] [Full Text] [Related]

  • 38. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients.
    Richiardi L, Fiano V, Vizzini L, De Marco L, Delsedime L, Akre O, Tos AG, Merletti F.
    J Clin Oncol; 2009 Jul 01; 27(19):3161-8. PubMed ID: 19470943
    [Abstract] [Full Text] [Related]

  • 39. Methylated genes as potential biomarkers in prostate cancer.
    Phé V, Cussenot O, Rouprêt M.
    BJU Int; 2010 May 01; 105(10):1364-70. PubMed ID: 20067451
    [Abstract] [Full Text] [Related]

  • 40. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
    Rouprêt M, Hupertan V, Yates DR, Catto JW, Rehman I, Meuth M, Ricci S, Lacave R, Cancel-Tassin G, de la Taille A, Rozet F, Cathelineau X, Vallancien G, Hamdy FC, Cussenot O.
    Clin Cancer Res; 2007 Mar 15; 13(6):1720-5. PubMed ID: 17363525
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.